HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuhiko Osaki Selected Research

Core Binding Factor Alpha 3 Subunit

1/2007Runt-related transcription factor 3 expression in human oral squamous cell carcinomas; implication for tumor progression and prognosis.
4/2005Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis.
1/2005Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuhiko Osaki Research Topics

Disease

44Neoplasms (Cancer)
09/2022 - 06/2003
20Carcinoma (Carcinomatosis)
01/2014 - 02/2002
14Carcinogenesis
02/2021 - 05/2004
13Neoplasm Metastasis (Metastasis)
09/2022 - 07/2005
5Adenocarcinoma
03/2022 - 01/2003
5Inflammation (Inflammations)
02/2021 - 11/2013
5Osteosarcoma (Osteogenic Sarcoma)
04/2019 - 03/2006
5Adenoma (Adenomas)
10/2018 - 01/2003
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2008
4Renal Cell Carcinoma (Grawitz Tumor)
11/2020 - 01/2014
4Squamous Cell Carcinoma of Head and Neck
07/2016 - 01/2007
4Sarcoma (Soft Tissue Sarcoma)
09/2008 - 06/2003
3Melanoma (Melanoma, Malignant)
12/2020 - 09/2005
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 01/2009
3Stomach Neoplasms (Stomach Cancer)
06/2018 - 01/2007
3Foreign Bodies (Foreign Body)
12/2015 - 11/2013
3Glioma (Gliomas)
09/2012 - 05/2007
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2007 - 02/2002
3Cardiomegaly (Heart Hypertrophy)
01/2003 - 05/2002
2Liver Diseases (Liver Disease)
01/2021 - 10/2008
2Endometriosis
11/2018 - 01/2015
2Colonic Neoplasms (Colon Cancer)
10/2018 - 05/2014
2Rhabdomyosarcoma
06/2005 - 05/2002
2Adenocarcinoma of Lung
04/2005 - 01/2004
2Malignant Fibrous Histiocytoma
10/2004 - 11/2003
1Aneuploidy (Aneuploid)
03/2021
1Obstructive Jaundice (Cholestatic Jaundice)
01/2021
1Bisphosphonate-Associated Osteonecrosis of the Jaw
01/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2019

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
03/2022 - 05/2002
8MicroRNAs (MicroRNA)IBA
04/2019 - 01/2010
4Sirtuin 2IBA
09/2012 - 05/2007
4Thymidine PhosphorylaseIBA
09/2005 - 03/2003
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2005 - 05/2004
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2004 - 11/2003
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2021 - 02/2005
3Biological ProductsIBA
02/2021 - 01/2009
3Pharmaceutical PreparationsIBA
12/2020 - 04/2014
3Sunitinib (Sutent)FDA Link
11/2020 - 01/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 02/2008
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2019 - 04/2011
3Small Interfering RNA (siRNA)IBA
01/2019 - 01/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018 - 01/2004
3Biomarkers (Surrogate Marker)IBA
07/2016 - 01/2014
3ProteomeIBA
07/2010 - 01/2007
3Transcription Factor 3IBA
01/2008 - 04/2005
3Core Binding Factor Alpha 3 SubunitIBA
01/2007 - 01/2005
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2005 - 11/2003
3N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
03/2005 - 11/2003
3Fas Ligand Protein (Fas Ligand)IBA
03/2005 - 02/2002
3Paclitaxel (Taxol)FDA LinkGeneric
01/2004 - 03/2003
3Genetic Markers (Genetic Marker)IBA
01/2003 - 05/2002
2HMGB1 Protein (HMG1)IBA
09/2022 - 01/2022
2CytokinesIBA
02/2021 - 02/2005
2Tyrosine Kinase InhibitorsIBA
11/2020 - 01/2018
2EnzymesIBA
01/2019 - 04/2011
2Messenger RNA (mRNA)IBA
11/2018 - 02/2015
2fascinIBA
10/2018 - 05/2014
2Plasminogen Activator Inhibitor 1IBA
03/2018 - 01/2016
2CaspasesIBA
05/2014 - 03/2006
2Cysteine-Rich Protein 61IBA
07/2010 - 01/2007
2Histones (Histone)IBA
04/2009 - 05/2007
2TubulinIBA
04/2009 - 05/2007
2ParaffinIBA
09/2008 - 06/2005
2DNA (Deoxyribonucleic Acid)IBA
02/2008 - 07/2004
2Estrogen ReceptorsIBA
07/2005 - 06/2003
2Transcription Factors (Transcription Factor)IBA
07/2005 - 04/2005
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2004 - 01/2003
2Phosphatidylinositols (Phosphatidylinositol)IBA
04/2004 - 01/2004
22- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
04/2004 - 01/2004
2doxifluridineIBA
05/2003 - 03/2003
2Proline (L-Proline)FDA Link
01/2003 - 05/2002
1Monoclonal AntibodiesIBA
01/2022
1Indicators and Reagents (Reagents)IBA
04/2021
1Vitamin KFDA Link
01/2021
1Vitamin K 2 (Vitamin K2)IBA
01/2021
1Cystine (L-Cystine)IBA
12/2020
1AntiportersIBA
12/2020
1Glutamic Acid (Glutamate)FDA Link
12/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2020
1Diphosphonates (Bisphosphonates)IBA
01/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2019
1Singlet OxygenIBA
01/2019
1phthalocyanineIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Photosensitizing Agents (Photosensitizers)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
11/2018
1Estradiol (Delestrogen)FDA LinkGeneric
11/2018
1TS 108IBA
11/2018
1Selective Estrogen Receptor Modulators (SERM)IBA
11/2018
1LipopolysaccharidesIBA
11/2018

Therapy/Procedure

7Therapeutics
01/2022 - 03/2006
3Intravenous Injections
01/2017 - 06/2011
2Transplantation
01/2019 - 01/2009
2Drug Therapy (Chemotherapy)
07/2016 - 06/2003
1Cell- and Tissue-Based Therapy (Cell Therapy)
03/2021
1Blood Component Removal (Apheresis)
02/2021
1Ligation
01/2021
1Subcutaneous Injections
12/2020
1Photochemotherapy (Photodynamic Therapy)
01/2019